Zobrazeno 1 - 10
of 850
pro vyhledávání: '"сахарный диабет 2 типа"'
Autor:
I. N. Dyakov, S. K. Zyryanov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 4-15 (2021)
The effective control of Diabetes Mellitus (DM) is an actual problem from optimal expenditures of health care system point of view. Agonists of receptors for glucagon like peptide-1 (aGLP-1) are one of the modern option for glycemia control in DM Typ
Externí odkaz:
https://doaj.org/article/2785338f46e3440b9a200a40d238437b
Publikováno v:
Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, Vol 19, Iss 2, Pp 147-152 (2021)
Статины – препараты первой линии, которые используются для профилактики сердечно-сосудистых заболеваний. Они снижают риск развития ин
Externí odkaz:
https://doaj.org/article/a7142e834d0142cea26b373008250171
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 5, Pp 50-63 (2021)
Ipragliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduce plasma glucose concentrations by inhibiting glucose reabsorption by the kidney through inhibiting SGLT2 sodium-glucose cotransporter and induce glycosuria. SGLT
Externí odkaz:
https://doaj.org/article/3326312b1b5c4b98a97d9ae02c8e1e68
Autor:
I. N. Dyakov, S. K. Zyryanov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 5, Pp 4-14 (2021)
Insulin glargine 100 U/ml (iGla) is gradually giving way to a fixed combination of insulin glargine 100 U/ml+ lixisenatide (iGlaLixi) — an effective and safe drug for Diabetes Mellitus Type 2 (DM2T) control. It has demonstrated the economic benefit
Externí odkaz:
https://doaj.org/article/6232f7df4b864be7935f91493e808d7b
Autor:
I. N. Dyakov, S. K. Zyryanov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 4-14 (2020)
Second generation insulin analogue — insulin glargine 300 UI/ml (GLA-300) — can provide an effective control of Diabetes Mellitus (DM) with minimal risk of hypoglycemic events and prevent of cardiovascular complications or events (CVS). Pharmacoe
Externí odkaz:
https://doaj.org/article/b21d93d5f0f84f3cb2adba3aa6e2d5ae
Publikováno v:
Сибирский научный медицинский журнал, Vol 38, Iss 3, Pp 43-48 (2019)
Objective: to research features of vegetative regulation and their relation to eating behavior in women with different types of obesity and type 2 diabetes. Methods. 106 women were examined; survey of women included anthropometric measurements, study
Externí odkaz:
https://doaj.org/article/c4c11c8da50c4e43840fca10b2ce4654
Autor:
S. К. Zyryanov, I. N. Dyakov
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 4-13 (2019)
Fixed antidiabetic drugs’ combinations have aim to improve of Diabetes Mellitus type 2 (DMT2) control as well as a safety treatment increasing. Soliqua SoloStar® is a new registered drug for control of fasting and prandial glucose levels, containe
Externí odkaz:
https://doaj.org/article/35aad042d19942e2b96e375dc25e8e77
Publikováno v:
Medicina v Kuzbasse, Vol 17, Iss 4, Pp 51-56 (2018)
Aim – assess the relationship between adiponectin, resistin and hormone-metabolic parameters in men with hypothyroidism and type 2 diabetes mellitus. Materials and methods. The study involved 62 men aged from 36 to 72 years, who were divided into
Externí odkaz:
https://doaj.org/article/d5597ef4e45147809b4f0b7781477a16
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 1-9 (2018)
Результаты. Инсулин гларгин по результатам несравнительных рандомизированных клинических исследований в сопоставимых группах больны
Externí odkaz:
https://doaj.org/article/d1b42cd8f4ab4d0c9bc24005be47ff71
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 85-91 (2018)
Актуальность. Диабетическая полиневропатия (ДПН) — одно из наиболее тяжёлых и часто встречающихся осложнений сахарного диабета (СД), ко
Externí odkaz:
https://doaj.org/article/f0fdc5d26d684f9a840f5cf1a3fb9756